BLT 0.00% 2.6¢ benitec biopharma limited

alnylam positive clinical results (headline on, page-23

  1. 13,608 Posts.
    lightbulb Created with Sketch. 4839

    Friday, July 20, 6:24 AM
    Alnylam Pharmaceuticals (ALNY) is in discussions with "more than one" potential partner to help it carry out Phase II and Phase III studies of its ALN-PCS treatment for high cholestoral, CEO John Maraganore says, although he declines to name names.

    From Seeking Alpha.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.